Life Expectancy After HIV Diagnosis Based on National HIV Surveillance Data From 25 States, United States

被引:177
作者
Harrison, Kathleen McDavid [1 ]
Song, Ruiguang [1 ]
Zhang, Xinjian [1 ]
机构
[1] Ctr Dis Control & Prevent, Off Hlth Equ, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Div HIV AIDS Prevent, Atlanta, GA 30333 USA
关键词
HIV; life expectancy; surveillance data; United States; ACTIVE ANTIRETROVIRAL THERAPY; MORTALITY; RISK; DEATH; INDIVIDUALS; SURVIVAL; HIV/AIDS; SERVICES; DISEASE; COHORT;
D O I
10.1097/QAI.0b013e3181b563e7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: We estimate life expectancy and average years of life lost (AYLL) after an HIV diagnosis using population-based surveillance data from 25 states that have had name-based HIV surveillance since 1996. Methods: We used US national HIV surveillance data (cases >= 13 years old) to model life expectancy after an HIV diagnosis using the life table approach. We then compared life expectancy at HIV diagnosis with that in the general population of the same age, sex, and race/ethnicity in the same calendar year using vital statistics data to estimate the AYLL due to an HIV diagnosis. Results: Average life expectancy after HIV diagnosis increased from 10.5 to 22.5 years from 1996 to 2005. Life expectancy (years) was better for females than for males but improved less for females (females: 12.6-23.6 and males: 9.9-210). In 2005, life expectancy for black males was shortest, followed by Hispanic males and then white males. AYLL for cases diagnosed in 2005 was 21.1 years (males: 19.1 and females: 22.7) compared with 32.9 years in 1996. Conclusions: Disparity in life expectancy for females and both black and Hispanic males, compared with males and white males, respectively, persists and should be addressed.
引用
收藏
页码:124 / 130
页数:7
相关论文
共 43 条
[1]  
*AD PREV TREATM OP, 2008, MMWR-MORBID MORTAL W, V58, P1
[2]  
ADIH WK, 2008, APHA ANN M SAN DIEG
[3]  
[Anonymous], 2006, Morbidity and Mortality Weekly Report, V57, P1073
[4]  
[Anonymous], 2003, MMWR-MORBID MORTAL W, V2, P329
[5]  
[Anonymous], 2000, HLTH PEOPL 2010, V2nd
[6]  
ARIAS E, 2007, NAT VIT STAT REP, V56
[7]   Changes in the risk of death after HIV seroconversion compared with mortality in the general population [J].
Bhaskaran, Krishnan ;
Hamouda, Osamah ;
Sannes, Mette ;
Boufassa, Faroudy ;
Johnson, Anne M. ;
Lambert, Paul C. ;
Porter, Kholoud .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (01) :51-59
[8]   Estimating the proportion of patients infected with HIV who wilt die of comorbid diseases [J].
Braithwaite, RS ;
Justice, AC ;
Chang, CCH ;
Fusco, JS ;
Raffanti, SR ;
Wong, JB ;
Roberts, MS .
AMERICAN JOURNAL OF MEDICINE, 2005, 118 (08) :890-898
[9]   Years of life lost (YLL) from cancer is an important measure of population burden - and should be considered when allocating research funds [J].
Burnet, NG ;
Jefferies, SJ ;
Benson, RJ ;
Hunt, DP ;
Treasure, FP .
BRITISH JOURNAL OF CANCER, 2005, 92 (02) :241-245
[10]  
*CDCP, GUID DEF PUBL HLTH R